Shares of BG Medicine, Inc. (OTCMKTS:BGMD) crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.01 and traded as high as $0.02. BG Medicine shares last traded at $0.02, with a volume of 2,751 shares.
The business has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.01.
About BG Medicine (OTCMKTS:BGMD)
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.